281
Views
19
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy

, , , , , , , , , , & show all
Pages 158-167 | Received 15 Dec 2014, Accepted 17 Dec 2014, Published online: 23 Apr 2015

References

  • 1980. Suicide and epilepsy. Br Med J 281:530.
  • Abraham G. 2003. Topiramate-induced suicidality. Can J Psychiatry 48:127–128.
  • Akiskal HS, Benazzi F, Perugi G, Rihmer Z. 2005. Agitated “unipolar” depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord 85:245–258.
  • Andersohn F, Schade R, Willich SN, Garbe E. 2010. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology 75:335–340.
  • Arana A, Wentworth CE, Ayuso-Mateos JL, Arellano FM. 2010. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 363:542–551.
  • Bagary M. 2011. Epilepsy, antiepileptic drugs and suicidality. Curr Opin Neurol 24:177–182.
  • Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, et al. 2011. General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci 261:207–245.
  • Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, et al. 2012. Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders. Eur Arch Psychiatry Clin Neurosci 262:13–22.
  • Balazs J, Benazzi F, Rihmer Z, Rihmer A, Akiskal KK, Akiskal HS. 2006. The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. J Affect Disord 91:133–138.
  • Baldessarini RJ, Tondo L, Hennen J. 2003. Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry 64:44–52.
  • Belcastro V, Gaetano G, Italiano D, Oteri G, Caccamo D, Pisani LR, et al. 2007. Antiepileptic drugs and MTHFR polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients. Epilepsia 48:1990–1994.
  • Bell GS, Gaitatzis A, Bell CL, Johnson AL, Sander JW. 2009a. Suicide in people with epilepsy: how great is the risk? Epilepsia 50: 1933–1942.
  • Bell GS, Mula M, Sander JW. 2009b. Suicidality in people taking antiepileptic drugs: What is the evidence? CNS Drugs 23:281–292.
  • Bell GS, Sander JW. 2009. Suicide and epilepsy. Curr Opin Neurol 22:174–178.
  • Berman ME, Jones GD, McCloskey MS. 2005. The effects of diazepam on human self-aggressive behavior. Psychopharmacology (Berl) 178:100–106.
  • Brent DA. 1986. Overrepresentation of epileptics in a consecutive series of suicide attempters seen at a children's hospital, 1978–1983. J Am Acad Child Psychiatry 25:242–246.
  • Canevini MP, De Sarro G, Galimberti CA, Gatti G, Licchetta L, Malerba A, et al. 2010. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 51:797–804.
  • Chouinard MJ, Nguyen DK, Clement JF, Bruneau MA. 2006. Catatonia induced by levetiracetam. Epilepsy Behav 8:303–307.
  • Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E. 2007. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 6:693–698.
  • Christman DS, Faubion MD. 2007. Suicide attempt following initiation of topiramate. Am J Psychiatry 164:682–683.
  • Cipriani A, Pretty H, Hawton K, Geddes JR. 2005. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 162:1805–1819.
  • Cockerell OC, Johnson AL, Sander JW, Hart YM, Goodridge DM, Shorvon SD. 1994. Mortality from epilepsy: results from a prospective population-based study. Lancet 344:918–921.
  • FDA. 2008. Statistical review and evaluation: antiepileptic drugs and suicidality. [online], http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4372b1-01-FDA.pdf [Internet].
  • Fountoulakis KN, Gonda X, Samara M, Siapera M, Karavelas V, Ristic DI, Iacovides A. 2012a. Antiepileptic drugs and suicidality. J Psychopharmacol 26:1401–1407.
  • Fountoulakis KN, Kasper S, Andreassen O, Blier P, Okasha A, Severus E, et al. 2012b. Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci 262:1–48.
  • Gibbons RD, Hur K, Brown CH, Mann JJ. 2009. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry 66:1354–1360.
  • Givon L, Porter S, Padmanabhan B, Goren J, Cohen PA. 2011. Levetiracetam, seizures, and suicidality. Harv Rev Psychiatry 19:47–55.
  • Hall RC, Joffe JR. 1972. Aberrant response to diazepam: a new syndrome. Am J Psychiatry 129:738–742.
  • Hancock JC, Bevilacqua AR. 1971. Temporal lobe dysrhythmia and impulsive or suicidal behavior: preliminary report. South Med J 64:1189–1193.
  • Harris EC, Barraclough B. 1997. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 170:205–228.
  • Hawton K, Fagg J, Marsack P. 1980. Association between epilepsy and attempted suicide. J Neurol Neurosurg Psychiatry 43:168–170.
  • Hesdorffer DC, Berg AT, Kanner AM. 2010. An update on antiepileptic drugs and suicide: are there definitive answers yet? Epilepsy Curr 10:137–145.
  • Hesdorffer DC, French JA, Posner K, DiVentura B, Pollard JR, Sperling MR, et al. 2013. Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials. Epilepsia 54:879–887.
  • Hesdorffer DC, Kanner AM. 2009. The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm? Epilepsia 50:978–986.
  • Iivanainen M, Lehtinen J. 1979. Causes of death in institutionalized epileptics. Epilepsia 20:485–91.
  • Ishihara L, Webb DJ, Irizarry M, Weil J. 2010. Exploring differential prescribing between anti-epileptic drugs in epilepsy patients with a history of mood disorders. Pharmacoepidemiol Drug Saf 19: 289–295.
  • Isometsa ET, Henriksson MM, Aro HM, Heikkinen ME, Kuoppasalmi KI, Lonnqvist JK. 1994. Suicide in major depression. Am J Psychiatry 151:530–536.
  • Kalinin VV. 2007. Suicidality and antiepileptic drugs: is there a link? Drug Saf 30:123–142.
  • Kandemir H, Yumru M, Kul M, Kandemir SB. 2008. Behavioral disinhibition, suicidal ideation, and self-mutilation related to clonazepam. J Child Adolesc Psychopharmacol 18:409.
  • Kanner AM. 2011. Are antiepileptic drugs used in the treatment of migraine associated with an increased risk of suicidality? Curr Pain Headache Rep 15:164–169.
  • Kaufman KR, Struck PJ. 2011. Activation of suicidal ideation with adjunctive rufinamide in bipolar disorder. Epilepsy Behav 20: 386–389.
  • Khan A, Faught E, Gilliam F, Kuzniecky R. 1999. Acute psychotic symptoms induced by topiramate. Seizure 8:235–237.
  • Klenerman P, Sander JW, Shorvon SD. 1993. Mortality in patients with epilepsy: a study of patients in long term residential care. J Neurol Neurosurg Psychiatry 56:149–152.
  • Kwon OY, Park SP. 2013. Frequency of affective symptoms and their psychosocial impact in Korean people with epilepsy: a survey at two tertiary care hospitals. Epilepsy Behav 26:51–56.
  • Leon AC, Demirtas H, Li C, Hedeker D. 2012a. Two propensity score-based strategies for a three-decade observational study: investigating psychotropic medications and suicide risk. Stat Med 31:3255–3260.
  • Leon AC, Solomon DA, Li C, Fiedorowicz JG, Coryell WH, Endicott J, Keller MB. 2012b. Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: a 30-year observational study. Am J Psychiatry 169:285–291.
  • Lip GY, Brodie MJ. 1992. Sudden death in epilepsy: an avoidable outcome? J R Soc Med 85:609–611.
  • Machado RA, Espinosa AG, Melendrez D, Gonzalez YR, Garcia VF, Rodriguez YQ. 2011. Suicidal risk and suicide attempts in people treated with antiepileptic drugs for epilepsy. Seizure 20:280–284.
  • Mago R, Huege S, Ahuja N, Kunkel EJ. 2006. Zonisamide-induced suicidal ideation. Psychosomatics 47:68–69.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. 2010. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–341.
  • Moller HJ, Baldwin DS, Goodwin G, Kasper S, Okasha A, Stein DJ, et al. 2008. Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci 258:3–23.
  • Mula M, Kanner AM, Schmitz B, Schachter S. 2013. Antiepileptic drugs and suicidality: an expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology. Epilepsia 54:199–203.
  • Mula M, Sander JW. 2007. Suicidal ideation in epilepsy and levetiracetam therapy. Epilepsy Behav 11:130–132.
  • Mula M, Sander JW. 2013. Suicide risk in people with epilepsy taking antiepileptic drugs. Bipolar Disord 15:622–627.
  • Nilsson L, Ahlbom A, Farahmand BY, Asberg M, Tomson T. 2002. Risk factors for suicide in epilepsy: a case control study. Epilepsia 43:644–651.
  • Nilsson L, Tomson T, Farahmand BY, Diwan V, Persson PG. 1997. Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy. Epilepsia 38: 1062–1068.
  • Olesen JB, Hansen PR, Erdal J, Abildstrom SZ, Weeke P, Fosbol EL, et al. 2010. Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Saf 19:518–524.
  • Patorno E, Bohn RL, Wahl PM, Avorn J, Patrick AR, Liu J, Schneeweiss S. 2010. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA 303:1401–1409.
  • Pereira A, Gitlin MJ, Gross RA, Posner K, Dworkin RH. 2013. Suicidality associated with antiepileptic drugs: implications for the treatment of neuropathic pain and fibromyalgia. Pain 154: 345–349.
  • Perlis RH. 2011. Hard outcomes: clinical trials to reduce suicide. Am J Psychiatry 168:1009–1011.
  • Pompili M, Baldessarini RJ. 2010. Epilepsy: risk of suicidal behavior with antiepileptic drugs. Nat Rev Neurol 6:651–653.
  • Pompili M, Girardi P, Tatarelli G, Angeletti G, Tatarelli R. 2006. Suicide after surgical treatment in patients with epilepsy: a meta-analytic investigation. Psychol Rep 98:323–338.
  • Pompili M, Tatarelli R, Girardi P, Tondo L, Baldessarini RJ. 2010. Suicide risk during anticonvulsant treatment. Pharmacoepidemiol Drug Saf 19:525–528.
  • Procopio M. 2010. New users of the anticonvulsants gabapentin, lamotrigine, oxcarbazepine or tiagabine are at increased risk of suicidal acts compared with new users of topiramate. Evid Based Ment Health 13:102.
  • Prudhomme C. 1941. Epilepsy and suicide. J Nerv Ment Dis 94: 722–727.
  • Pugh MJ, Copeland LA, Zeber JE, Wang CP, Amuan ME, Mortensen EM, et al. 2012. Antiepileptic drug monotherapy exposure and suicide-related behavior in older veterans. J Am Geriatr Soc 60:2042–2047.
  • Pugh MJ, Hesdorffer D, Wang CP, Amuan ME, Tabares JV, Finley EP, et al. 2013. Temporal trends in new exposure to antiepileptic drug monotherapy and suicide-related behavior. Neurology 81:1900–1906.
  • Reinares M, Rosa AR, Franco C, Goikolea JM, Fountoulakis K, Siamouli M, et al. 2013. A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression. Int J Neuropsychopharmacol 16:485–496.
  • Rihmer Z. 2007. Suicide risk in mood disorders. Curr Opin Psychiatry 20:17–22.
  • Rihmer Z, Akiskal H. 2006. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries . J Affect Disord 94:3–13.
  • Rosa AR, Fountoulakis K, Siamouli M, Gonda X, Vieta E. 2011. Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials . CNS Neurosci Ther 17:167–177.
  • Rudzinski LA, Meador KJ. 2011. Epilepsy: five new things. Neurology 76:S20–25.
  • Ryan HF, Merrill FB, Scott GE, Krebs R, Thompson BL. 1968. Increase in suicidal thoughts and tendencies. Association with diazepam therapy. JAMA 203:1137–1139.
  • Schmitz EB, Robertson MM, Trimble MR. 1999. Depression and schizophrenia in epilepsy: social and biological risk factors. Epilepsy Res 35:59–68.
  • Shneker BF, Cios JS, Elliott JO. 2009. Suicidality, depression screening, and antiepileptic drugs: reaction to the FDA alert. Neurology 72:987–991.
  • Sperling MR, Feldman H, Kinman J, Liporace JD, O’Connor MJ. 1999. Seizure control and mortality in epilepsy. Ann Neurol 46:45–50.
  • Striano P, Zara F, Minetti C. 2010. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 363:1873–1874; author reply 1874.
  • Tandon R, Belmaker RH, Gattaz WF, Lopez-Ibor JJ Jr, Okasha A, Singh B, et al. 2008. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res 100:20–38.
  • VanCott AC, Cramer JA, Copeland LA, Zeber JE, Steinman MA, Dersh JJ, et al. 2010. Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med 8:4.
  • Wen X, Meador KJ, Loring DW, Eisenschenk S, Segal R, Hartzema AG. 2011. Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy? Epilepsy Behav 19:494–500.
  • White SJ, McLean AE, Howland C. 1979. Anticonvulsant drugs and cancer. A cohort study in patients with severe epilepsy. Lancet 2:458–461.
  • Zebley BD, Ferrando SJ. 2010. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 363:1873; author reply 1874.
  • Zielinski JJ. 1974. Epilepsy and mortality rate and cause of death. Epilepsia 15:191–201.
  • Ziemba KS, O’Carroll CB, Drazkowski JF, Wingerchuk DM, Hoffman-Snyder C, Wellik KE, Demaerschalk BM. 2010. Do antiepileptic drugs increase the risk of suicidality in adult patients with epilepsy?: A critically appraised topic. Neurologist 16:325–328.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.